Péter Hajdú - Concepedia

Author

Péter Hajdú

University of Debrecen ORCID

Also Known As

A HAEUSSLER, Hajdu, Péter, P HAJDU, P Hajdu, P Hajdù, P Hajdú, P. HAJDÚ, P. Hajdu, P. Hajdú, Patrik Hajdu

185

Publications

1.9K

Citations

H-Index

109

Concepts

All Affiliations

University of Debrecen Hungarian Academy of Sciences University of Cincinnati HUN-REN Institute for Nuclear Research RAG Aktiengesellschaft (Germany)

About

Péter Hajdú is an author at University of Debrecen specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	866
2	Natural Sciences	6	6	160
3	Engineering	4	4	79
4	Education	1	1	28
5	Health Sciences	1	1	45

Péter Hajdú

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of single and multiple doses of clobazam in humans. W Rupp, M. Badian, O Christ, British Journal of Clinical Pharmacology Pharmacokinetic ModelingPharmacological StudyMultiple DosesPharmacologyMedication N‐desmethylclobazam	1979	101
Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K+-channels with distinctly different affinities César V.F. Batista, Froylán Gómez‐Lagunas, Ricardo C. Rodŕıguez de la Vega, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics BiologyToxinologyEntomologyVenomicsDifferent Affinities	2002	91
Cholesterol modifies the gating of Kv1.3 in human T lymphocytes Péter Hajdú, Zoltán Varga, Carlo Pieri, Pflügers Archiv - European Journal of Physiology InflammationMolecular PhysiologyLymphocyte DevelopmentPhysiologyImmunology	2003	90
Kinetics and metabolism of clobazam in animals and man. M. Volz, O Christ, HM Kellner, British Journal of Clinical Pharmacology	1979	85
Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels Ádám Bartók, Ágnes Tóth, Sándor Somodi, Toxicon Molecular PharmacologyInhibitory ActivitySignal TransductionMolecular PhysiologyMedicine	2014	81
<p>Investigation of silver nanoparticles on titanium surface created by ion implantation technology</p> István Lampé, Dezső L. Beke, S. Biri, International Journal of Nanomedicine	2019	69
A defect in KCa3.1 channel activity limits the ability of CD8 <sup>+</sup> T cells from cancer patients to infiltrate an adenosine-rich microenvironment Ameet A. Chimote, András Balajthy, Michael J. Arnold, Science Signaling	2018	67
Developmental Switch of the Expression of Ion Channels in Human Dendritic Cells Emese Zsíros, Katalin Kis‐Tóth, Péter Hajdú, The Journal of Immunology ImmunologyCellular NeurobiologyCellular PhysiologyInflammationHyperpolarization (Biology)	2009	56
Selective Inhibition of KCa3.1 Channels Mediates Adenosine Regulation of the Motility of Human T Cells Ameet A. Chimote, Péter Hajdú, Vladimir Kucher, The Journal of Immunology Abstract AdenosineImmunologyImmune RegulationImmunologic MechanismImmunotherapeutics	2013	56
Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer Ameet A. Chimote, Péter Hajdú, Alexandros M. Sfyris, Cancer Research	2016	53

Page 1